Advokatfirman Lindahl acts as an adviser in Abboxia’s merger with FrostPharma
Advokatfirman Lindahl represented the sellers of Abboxia in the strategic merger with FrostPharma. The two companies are now merging under the name of FrostPharma and will thus become one of the leading specialist pharmaceutical companies with the widest range of hospital drugs in the Nordic Region.
The merger combines FrostPharma’s commercial strength and strategic alliances with Abboxia’s development capacity, thus allowing more extensive supply of hospital medicines to Nordic healthcare providers.
The Lindahl team consisted of Svante Liljedahl, Olivia Sandin and Jannica Stefansson.
About FrostPharma and Abboxia
FrostPharma, which was founded in 2016, focuses on strategic partnerships and commercialisation of specialist pharmaceuticals in the Nordic market. Abboxia, which was founded in 2017, has developed several specialist medicines for the hospital segment in the Nordic Region.
Read more in the FrostPharma press release here.
Carousel items
-
Knowledge
8/22/2025
Dispute boards in construction disputes
In larger construction projects, it is internationally common to establish a dispute board – a special panel that, during the course of the project, continuously helps resolve disagreements between the parties. This alternative dispute resolution...
-
Portraits
8/19/2025
From demand letters to culture – Josefin on life as a summer trainee
Getting a real feel for what it's like to work as a lawyer was Josefin Mannevik's goal when she joined Lindahl's Gothenburg office as a summer trainee. A few weeks later, she has not only immersed herself in bankruptcy law, legal monitoring and si...
-
News articles
8/18/2025
Lindahl wins in the Supreme Court - bankruptcy cancelled for debt-free company
Lindahl has successfully represented ParkingSolar Nordic AB in a bankruptcy dispute that was decided in the company's favour by the Supreme Court. The case raises important questions about when presumption rules for insolvency can be applied.
-
Cases and transactions
8/13/2025
Lindahl advises Lyten on its acquisition of Northvolt
Lindahl has advised the US global leader in lithium-sulfur batteries Lyten Inc. on its recently announced transaction pursuant to which it has entered into a binding agreement to acquire all of Northvolt's remaining assets in Sweden and Germany.
-
Read more news and insights?
